Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple myeloma: A tale of deregulated transcription factors.

HemaSphere·2026
Same author

An injectable nanoreinforced hydrogel for combined GDNF-loaded nanoparticles and mesenchymal stem cell therapy in Parkinson's disease.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same author

Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response.

Nature communications·2026
Same author

IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma.

Blood·2026
Same author

Injectable pre-vascularized alginate-collagen hydrogel with sustained delivery of miR-133a-loaded lipid nanoparticles for myocardial repair.

Drug delivery and translational research·2026
Same author

Epicardial extracellular vesicles modulate gene expression following ischemia-reperfusion injury in heart-on-a-chip.

Materials today. Bio·2026
Same journal

Preventing tablet defects through vacuum-assisted deaeration of a powder bed.

International journal of pharmaceutics·2026
Same journal

Approaches for enhancing bioavailability of macromolecular drugs.

International journal of pharmaceutics·2026
Same journal

Characteristics of asymmetric microcrystalline solidification pellets and a better prediction for bioequiavailability based on solubility-permeability theory.

International journal of pharmaceutics·2026
Same journal

A CFPD-FSI analysis of the impact of nasal hairs on airflow patterns, nasal resistance, and particle filtration in a realistic human nasal airway.

International journal of pharmaceutics·2026
Same journal

Transient hydrate formation during disintegration of film-coated pharmaceutical tablets.

International journal of pharmaceutics·2026
Same journal

Erratum to "In vitro - In vivo correlation modeling of an oxcarbezapine extended-release formulation using numerical deconvolution" [Int. J. Pharm. 699 (2026) 126952].

International journal of pharmaceutics·2026
See all related articles

Related Experiment Video

Updated: Mar 10, 2026

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering
10:18

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering

Published on: September 19, 2011

26.1K

Hydrogel based approaches for cardiac tissue engineering.

Laura Saludas1, Simon Pascual-Gil1, Felipe Prósper2

  • 1Pharmacy and Pharmaceutical Technology Department, School of Pharmacy, Universidad de Navarra, Pamplona, C/Irunlarrea 1, E-31080, Spain; Instituto de Investigación Sanitaria de Navarra, IdiSNA, Pamplona, C/Irunlarrea 3, E-31008 Pamplona, Spain.

International Journal of Pharmaceutics
|December 20, 2016
PubMed
Summary
This summary is machine-generated.

Hydrogels offer a promising solution for heart failure treatment by improving the delivery and effectiveness of stem cells and growth factors for cardiac tissue regeneration. These biomaterials enhance cell viability and enable minimally invasive delivery, advancing drug and cell therapies.

Keywords:
BiomaterialCell therapyHydrogelMyocardial infarctionProtein therapyTissue engineering

More Related Videos

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
09:19

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model

Published on: September 20, 2020

5.0K
Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
10:42

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform

Published on: June 15, 2021

5.7K

Related Experiment Videos

Last Updated: Mar 10, 2026

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering
10:18

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering

Published on: September 19, 2011

26.1K
Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
09:19

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model

Published on: September 20, 2020

5.0K
Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
10:42

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform

Published on: June 15, 2021

5.7K

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Cardiovascular Research

Background:

  • Heart failure remains a primary global cause of mortality.
  • Current stem cell and growth factor therapies face challenges in clinical translation.
  • Biomaterials are emerging as key facilitators for cardiac repair strategies.

Purpose of the Study:

  • To review recent advancements in hydrogel-based biomaterials for cardiac tissue regeneration.
  • To explore different hydrogel types, compositions, and encapsulated therapeutic agents.
  • To highlight the potential of hydrogels in improving drug and cell delivery for heart repair.

Main Methods:

  • Review of current literature on hydrogels for cardiac regeneration.
  • Categorization of hydrogels by type (conventional, injectable, smart, nano-/micro-gels).
  • Analysis of biomaterial sources (natural, synthetic, hybrid) and encapsulated agents (stem cells, proteins).

Main Results:

  • Hydrogels show significant promise as advanced drug delivery systems for cardiac repair.
  • Injectable and smart hydrogels offer improved delivery and controlled release of therapeutics.
  • Various biomaterial compositions can be tailored for optimal cell viability and tissue integration.

Conclusions:

  • Hydrogel-based approaches represent a significant advancement in cardiac tissue regeneration.
  • These biomaterials enhance the efficacy of stem cell and protein therapies for heart failure.
  • Novel hydrogel strategies are poised to revolutionize drug delivery and cell-based treatments for cardiovascular diseases.